| Reagan-Udall Foundation

Read more about Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

On December 18, 2023, Dr. Brian King, the Director of FDA’s Center for Tobacco Products announced the Center’s new five-year strategic plan which outlines the Center’s programmatic and workforce initiatives and includes five goals, ten outcomes, and several corresponding objectives.

Coverage

Read more about CTP Releases New 5-year Strategic Plan - LexBlog

Today, the FDA is releasing several scientific review policy memoranda that provide a snapshot of the FDA's internal thinking on certain topics within the premarket tobacco review process.

Coverage

Read more about FDA Roundup - Associated Press

Read more about Real-World Evidence Webinar Series: Considerations Regarding Non-Interventional Studies for Drug and Biological Products

Join the Reagan-Udall Foundation and FDA for a Real-World Evidence Webinar on May 30, 2024, discussing key considerations for non-interventional studies in drug and biologic product development.